19 / 36
Best Radiographic Response by Level of Greatest Confirmed PSA Decline From Baseline
Within First 3 Months of Treatment on Enzalutamide Arm of PREVAIL (ITT Patients With
Measurable Disease)
Armstrong AJ et al. Cancer.2017;123: 2303-11